metabolomics drug
Evidence from:
primary |
all sources
Related entities (2)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| metabolomics | associated_with | behavioral development | — | 1 |
| metabolomics | associated_with | brain development | — | 1 |
Mentioned in (6)
Papers in which this entity is mentioned.
- Consortium profile: the methylation, imaging and NeuroDevelopment (MIND) consortium. (2026)
- Synthetic augmentation of cancer cell line multi-omic datasets using unsupervised deep learning. (2024)
- Consortium Profile: The Methylation, Imaging and NeuroDevelopment (MIND) Consortium. (2024)
- Large-scale collaboration in ENIGMA-EEG: A perspective on the meta-analytic approach to link neurological and psychiatric liability genes to electrophysiological brain activity. (2021)
- Cohort Profile: Pregnancy And Childhood Epigenetics (PACE) Consortium. (2018)
- Extending the MR-Egger method for multivariable Mendelian randomization to correct for both measured and unmeasured pleiotropy. (2017)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| metabolomics | drug | 6 | 8 |